scispace - formally typeset
Open AccessJournal ArticleDOI

The chronicles of modern movement disorders in India

TLDR
A chronicle of Indian Movement Disorders is written based on personal interviews with various senior Movement Disorder specialists of India as mentioned in this paper, which is a right time to look back into the history of Indian Neurology with specific reference to the Movement Disorders and pen down these chronicles since the inception of modern neurology in India.
Abstract
Movement Disorders are currently growing to be one of the major subspecialties of neurology worldwide, primarily by developments of research and therapeutics in this field. As any specialty grows, it leads to the formation of its society and the publication of journal to disseminate the knowledge. The International Parkinson’s Disease and Movement Disorders Society (IPMDS, formerly known as Movement Disorders Society) played its role with inception since 1980s. Further development of Movement Disorders subspecialty leads each region and country to have their own national societies and publications. Similarly, the seeds of Movement Disorders were sown in India in mid-1980s but it took a major stride in last few years with the formation of Movement Disorders Society of India (MDSI) in 2014 and following this, it is now at the crux of starting its journal—Annals of Movement Disorders (AOMD). This would be a right time to look back into the history of Indian Neurology with specific reference to the Movement Disorders and pen down these chronicles since the inception of modern neurology in India. The current chronicles of Indian Movement Disorders is penned based on personal interviews with various senior Movement Disorder specialists of India. However, it should also be remembered that many of the chronicles are limited by the memories of people and their biases with whom the interviews are conducted.

read more

References
More filters
Journal ArticleDOI

Two-Year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease

TL;DR: This 2‐year, controlled study of add‐on safinamide in mid‐to‐late Parkinson's disease with motor fluctuations showed improvement in dyskinesia in patients at least moderately dyskinetic at baseline, and demonstrated significant clinical benefits in ON‐time (without troublesome dysKinesia), OFF‐time, activities of daily living, motor symptoms, quality of life, and symptoms of depression.
Journal ArticleDOI

A novel Global Assessment Scale for Wilson's Disease (GAS for WD)

TL;DR: A two tier, Global Assessment Scale for Wilson's Disease (GAS for WD) that grades the multisystemic manifestations of the disease is proposed and longitudinal follow‐up over 1.5 years showed that the scale was sensitive to clinical change.